Douglas Adam Rubinson MD PhD (He/Him)

Gastrointestinal Cancer

Assistant Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School

450 Brookline AvenueBoston, MA 02215
Phone+1 617-632-4405
Fax+1 617-632-5370

Dr. Rubinson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rubinson's full profile Already have an account?

Summary

Dr. Douglas Rubinson is an oncologist based in Boston, MA, specializing in gastrointestinal cancer. He completed his medical education and training at prestigious institutions, including a fellowship in Hematology and Medical Oncology from Dana Farber. Since 2014, he has been on the faculty at Dana Farber and is currently an Assistant Professor. Dr. Rubinson has expertise in several cancers, such as pancreatic cancer and cholangiocarcinoma, and has published multiple research articles in notable oncology journals.

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2010 - 2014
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2010
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2007 - 2008
Harvard Medical SchoolClass of 2007

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2009 - 2028
ME State Medical License 2023 - 2028
VT State Medical License 2022 - 2026
NH State Medical License 2024 - 2024
RI State Medical License 2020 - 2020
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017

Publications & Presentations

PubMed

Dendritic cell redundancy enables priming of anti-tumor CD4T cells in pancreatic cancer.
Courtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, Victoire Cardot-Ruffino, Dennis A Agardy
Cancer Cell. 2026-07-13
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Kimberly J Perez, Andressa Dias Costa, Alexander Jordan, Thomas B Karasic, Dalia Elganainy
Nature Cancer. 2026-06-01
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.
Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, Nora Horick, Yvonne Y Li
Clinical Cancer Research. 2026-05-01

Journal Articles

Diabetes, Weight Change, and Pancreatic Cancer Risk
Douglas A Rubinson, Kimmie Ng, Brian M Wolpin, JAMA Oncology
Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer
Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature